A major international funder of research and public health efforts on debilitating infectious diseases has frozen hundreds of millions of dollars in grant money to China amidst questions about the country's use of the funds. In November, the Global Fund to Fight AIDS, Tuberculosis and Malaria halted payment of $283 million in AIDS grants to China after discovering that the government had breached an agreement by sharing too small a chunk of the money with independent community groups. Then, earlier this month, the Global Fund decided to freeze all funding to the communist nation because an internal investigation turned up evidence of further misuse of the money and fuzzy financial record keeping on local government levels. The Chinese government has until June 7th to respond to the Global Funds concerns or it risks losing $300 million in funding over the next few years for programs aimed at fighting disease in the country.
The head of GlaxoSmithKline’s Shanghai neurodegenerative-disease research unit is axed after irregularities are uncovered in a 2010 paper he published.